FDA Inspection 1227979 — Rishi Kakar, M.D.
The FDA completed an inspection of Rishi Kakar, M.D. on January 22, 2024 in Miami Lakes, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 22, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Miami Lakes, FL (United States)
Additional Details
Clinical Investigator (CI)